278 related articles for article (PubMed ID: 11925908)
61. Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
Pohlers D; Huber R; Ukena B; Kinne RW
Arthritis Rheum; 2006 Mar; 54(3):788-94. PubMed ID: 16508943
[TBL] [Abstract][Full Text] [Related]
62. Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography.
Peake NJ; Foster HE; Khawaja K; Cawston TE; Rowan AD
Ann Rheum Dis; 2006 Apr; 65(4):501-7. PubMed ID: 16150790
[TBL] [Abstract][Full Text] [Related]
63. Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment.
Lin B; Kidder JM; Noring R; Steere AC; Klempner MS; Hu LT
J Infect Dis; 2001 Jul; 184(2):174-80. PubMed ID: 11424014
[TBL] [Abstract][Full Text] [Related]
64. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
[TBL] [Abstract][Full Text] [Related]
65. Relative expression of matrix metalloproteinase-2 and -9 in synovial fluid from healthy calves and calves with experimentally induced septic arthritis.
Francoz D; Desrochers A; Simard N; Saint Pierre Y; Fecteau G; Latouche JS; Fortin M
Am J Vet Res; 2008 Aug; 69(8):1022-8. PubMed ID: 18672966
[TBL] [Abstract][Full Text] [Related]
66. Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis.
Blaschke S; Middel P; Dorner BG; Blaschke V; Hummel KM; Kroczek RA; Reich K; Benoehr P; Koziolek M; Müller GA
Arthritis Rheum; 2003 Jul; 48(7):1858-72. PubMed ID: 12847680
[TBL] [Abstract][Full Text] [Related]
67. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
68. Differential expression of matrix metalloproteinases and cyclooxygenases in synovial cells exposed to Borrelia burgdorferi.
Singh SK; Morbach H; Nanki T; Faber C; Baar V; Girschick HJ
Inflamm Res; 2004 Dec; 53(12):689-96. PubMed ID: 15654517
[TBL] [Abstract][Full Text] [Related]
69. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disorders.
Ishimaru JI; Oguma Y; Goss AN
Br J Oral Maxillofac Surg; 2000 Aug; 38(4):354-9. PubMed ID: 10922168
[TBL] [Abstract][Full Text] [Related]
70. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
[TBL] [Abstract][Full Text] [Related]
71. [Collagenase production increases in rheumatoid arthritis and osteoarthritis synoviocytes incubated].
Montrull HL; Brizuela NY; Demurtas SL; Strusberg AM; Spitale LS; Meirovich CI
Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(1):51-7. PubMed ID: 11188854
[TBL] [Abstract][Full Text] [Related]
72. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis.
Tomita T; Nakase T; Kaneko M; Shi K; Takahi K; Ochi T; Yoshikawa H
Arthritis Rheum; 2002 Feb; 46(2):373-8. PubMed ID: 11840439
[TBL] [Abstract][Full Text] [Related]
73. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker.
Gruber BL; Sorbi D; French DL; Marchese MJ; Nuovo GJ; Kew RR; Arbeit LA
Clin Immunol Immunopathol; 1996 Feb; 78(2):161-71. PubMed ID: 8625558
[TBL] [Abstract][Full Text] [Related]
74. Glutathione reductase activity correlates with concentration of extracellular matrix degradation products in synovial fluid from patients with joint diseases.
Sredzińska K; Galicka A; Porowska H; Sredziński Ł; Porowski T; Popko J
Acta Biochim Pol; 2009; 56(4):635-40. PubMed ID: 19847325
[TBL] [Abstract][Full Text] [Related]
75. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis.
Ståhle-Bäckdahl M; Sandstedt B; Bruce K; Lindahl A; Jiménez MG; Vega JA; López-Otín C
Lab Invest; 1997 May; 76(5):717-28. PubMed ID: 9166290
[TBL] [Abstract][Full Text] [Related]
76. Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis.
Haq A; El-Ramahi K; Al-Dalaan A; Al-Sedairy ST
J Med; 1999; 30(1-2):51-60. PubMed ID: 10515240
[TBL] [Abstract][Full Text] [Related]
77. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.
Pozgan U; Caglic D; Rozman B; Nagase H; Turk V; Turk B
Biol Chem; 2010 May; 391(5):571-9. PubMed ID: 20180636
[TBL] [Abstract][Full Text] [Related]
78. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis.
Kim KS; Choi HM; Lee YA; Choi IA; Lee SH; Hong SJ; Yang HI; Yoo MC
Rheumatol Int; 2011 Apr; 31(4):543-7. PubMed ID: 20665024
[TBL] [Abstract][Full Text] [Related]
79. Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta.
Ainola MM; Mandelin JA; Liljeström MP; Li TF; Hukkanen MV; Konttinen YT
Clin Exp Rheumatol; 2005; 23(5):644-50. PubMed ID: 16173240
[TBL] [Abstract][Full Text] [Related]
80. Implication of MMP-9 and urokinase plasminogen activator (uPA) in the activation of pro-matrix metalloproteinase (MMP)-13.
Kim KS; Lee YA; Choi HM; Yoo MC; Yang HI
Rheumatol Int; 2012 Oct; 32(10):3069-75. PubMed ID: 21913037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]